Clinical trial Recruiting at 3 sites Observational Ages 50 and up

Using an osteoporotic fracture score to guide treatment for thoracic and lumbar spine fractures

Official title: The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures: An International Multicenter Prospective Study

Run by AO Foundation, AO Spine · NCT07027306 · Data updated 2026-11-12

This study will try using the OF (osteoporotic fracture) score to help doctors decide between surgery and non-surgical care for older adults with painful thoracic or lumbar osteoporotic fractures.

More Osteoporosis trials

Quick facts

Study typeObservational
Ages50 Years and up
SexAll
Enrollment648 (estimated)
SponsorAO Foundation, AO Spine
Academic / other
Locations15 sites (San Francisco, California and 14 other locations)
StatusRecruiting
StartedMarch 19, 2026
Main results expectedDecember 1, 2028
Study endsDecember 1, 2030
Registry record updatedMay 13, 2026
Trial IDNCT07027306 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are postmenopausal women aged 50 or older and men older than 60 with new, symptomatic, contiguous thoracic or lumbar fractures from primary osteoporosis confirmed by MRI or CT.

Probably not a fit

Patients with secondary causes of osteoporosis, noncontiguous or non-thoracolumbar fractures, younger patients, or those unable to attend a participating site are not likely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an international, prospective, multicenter observational study enrolling older adults with symptomatic, radiologically confirmed contiguous thoracic or lumbar (T1–L5) fractures caused by primary osteoporosis. Each eligible fracture is classified with the OF (osteoporotic fracture) system and the most severe lesion is used to calculate an OF score. Treating surgeons make an initial plan of either surgical or nonsurgical care, and patients are grouped by whether that plan agrees with the OF score recommendation (accordance) or not (discordance). The protocol defines accordance as surgical treatment when the OF score is > 6 and nonsurgical treatment when the OF score is < 6, and investigators will compare the two groups to characterize treatment patterns and outcomes.

Why it matters

Potential benefit: If successful, using the OF score could lead to clearer treatment choices so more patients receive the most appropriate surgical or non-surgical care.

How similar studies have gone: Related classification systems have shown promise in retrospective or single-center reports, but large prospective multicenter validation of the OF-based decision score is still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Postmenopausal women ≥ 50 years old or men \> 60 years old

  o Menopause refers to amenorrhea for 1 complete year.
* Radiologically confirmed new diagnosis of symptomatic, single or multilevel TL (from T1 to L5) fractures, ie, the index fracture(s).

  * In case of a multilevel fracture, the fracture must be contiguous.
  * The index fracture is confirmed by MRI as an insufficiency (or fragility) fracture or is confirmed by CT or MRI as traumatic fracture (low-energy trauma)
* The index fracture(s) is a result of primary osteoporosis. Diagnosis of primary osteoporosis is based on any of the followings in the absence of causes for secondary osteoporosis (such as long-term use of steroids, rheumatoid arthritis, type 1 diabetes mellitus \[DM\], and other metabolic bone disorders \[eg, rickets/osteomalacia, Paget's disease, osteogenesis imperfecta, and primary hyperparathyroidism\]) \[13-15\]:

  * A T-score ≤ -2.5 in the lumbar spine, femoral neck, total hip, or 1/3 radius
  * Presence of fragility fracture (either a previous fragility fracture or the index fracture is a fragility fracture). Fragility fractures are fractures due to no or low-energy trauma, eg, slips, trips, or falls from less than double the body height, and heavy lifting.
* The index osteoporotic TL fracture being classified based on the OF Classification from OF 1 to OF 5:

  * OF 1: No deformation (vertebral body edema on MRI using short tau inversion recovery \[STIR\] sequence)
  * OF 2: Deformation of one endplate
  * OF 3: Deformation of one endplate with distinct posterior wall involvement
  * OF 4: Deformation of both endplates with/without posterior wall involvement
  * OF 5: Injuries with anterior or posterior tension band failure
* Ability to provide informed consent according to the EC/IRB defined and approved procedures

Exclusion Criteria:

* Patients with spinal tumors
* Patients with concomitant cervical fractures
* Patients showing any signs of spinal infections
* Patients with fractures due to high-energy or high-impact trauma, eg, a fall from double the body height or higher, motor vehicle accident with \> 100 km/h in cars with airbags, or motor vehicle accident \> 50 km/h without airbags, polytrauma
* Patients with concomitant fracture in the pelvis, upper extremities, and/or lower extremities which could affect the main study outcomes (specifically, patient mobility and pain)
* Patients for whom no FUs are possible
* Previous instrumented surgery in the affected spine levels
* Patients with single-level fracture or contiguous multilevel fracture adjacent to previous instrumented surgery
* Patients who are mentally impaired and therefore not able to adhere to the study procedures and data collection
* Patients who are bedridden before the index fracture
* Recent history of substance abuse (ie, recreational drugs and alcohol) that would preclude reliable assessments
* Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study

Where it's running

  • Island Hospital Spine Centre
    George Town, Malaysia
    Recruiting
  • Spiatlul Clinic De Urgenta, "Profesor Doctor Nicolae Oblu"
    Iași, Romania
    Recruiting
  • Security Force Hospital
    Riyāḑ, Saudi Arabia
    Recruiting
  • University of California San Francisco (USCF) Department of Orthopaedic Surgery
    San Francisco, California, United States
    Not yet recruiting
  • Thomas Jefferson University Hospital
    Philadelphia, Pennsylvania, United States
    Not yet recruiting
  • Sanatorio Güemes
    Buenos Aires, Argentina
    Not yet recruiting
Show 9 more locations
  • Cajuru University Hospital
    Curitiba, Brazil
    Not yet recruiting
  • Department of Orthopedic Surgery, Clinica Alemana de Santiago
    Santiago, Chile
    Not yet recruiting
  • Orthopaedic Department, Assiut University Hospitals, Faculty of Medicine
    Asyut, Egypt
    Not yet recruiting
  • Tampere University Hospital
    Tampere, Finland
    Not yet recruiting
  • Center for Spinal and Scoliosis Surgery, Malteser Waldkrankenhaus St. Marien
    Erlangen, Germany
    Not yet recruiting
  • PGIMER - Postgraduate Institute of Medical Education and Research
    Chandigarh, India
    Not yet recruiting
  • Dokkyo Medical University Hospital
    Tochigi, Japan
    Not yet recruiting
  • Spital Emmental - Orthopädie Sonnenhof
    Burgdorf, Switzerland
    Not yet recruiting
  • King's College Hospital
    London, United Kingdom
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Improving outcomes for patients with fragility fractures

    This study is testing if a new support program for older adults with recent bone fractures can help them recover better than standard care that just provides education.

    Recruiting at 23 sites University of Alabama at Birmingham · Birmingham, Alabama and 22 other locations · NCT06455085

  • Role of LH and hCG in adults being evaluated for endocrine disorders

    This study looks at whether levels of luteinizing hormone (LH) and hCG in adults undergoing endocrine evaluation relate to their disease presence and outcomes.

    Recruiting Copenhagen University Hospital at Herlev · Herlev · NCT07824102

  • Can a blood marker called lumican reveal hidden fragility in postmenopausal osteoporosis

    This study tests whether serum lumican levels can help identify hidden fragility risk in postmenopausal women beyond what bone density shows.

    Recruiting Kanuni Sultan Suleyman Training and Research Hospital · Küçükçekmece, Istanbul · NCT07677072

  • Functional Muscle-Bone Incongruity Index: A look at muscle strength and bone health in adults

    This observational study tests a composite FKUI score using handgrip strength and hip/spine bone density to see if it better reflects musculoskeletal health than each measure alone in adults undergoing routine DXA.

    Recruiting Kanuni Sultan Suleyman Training and Research Hospital · Küçükçekmece, Istanbul · NCT07677033

  • Vessel-X Bone Filling Container System for Vertebral Augmentation

    A new minimally invasive vertebral augmentation approach tests the Vessel-X device to see if it safely improves pain and function in people with osteoporotic vertebral compression fractures.

    Recruiting at 2 sites National Defense Medical Center, Taiwan · Taipei and 1 other locations · NCT07665424

  • Proximal Humerus Cortical Thickness in Post-Stroke Paresis

    This study tests whether measurements of the outer bone thickness of the upper arm (the humerus) on the paretic side after a stroke reflect regional bone loss and how well they agree with standard bone density tests.

    Recruiting Istanbul Physical Medicine Rehabilitation Training and Research Hospital · Istanbul · NCT07651306

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.